Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Scott Yaphe - aVenture Research

Scott Yaphe

AddedMar 31, 2024

UpdatedOct 12, 2026

Scott Yaphe

Scott Yaphe

Board Member, Selux Diagnostics

Scott Yaphe's Career

Selux Diagnostics

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Series C$172.5MCharlestown, MA, US

Board Member· Board

Hanger Network

$18MNew York City, NY, US

Board Member· Board

eXIthera Pharmaceuticals

Series B$18MWestborough, MA, US

Board Member· Board

Censinet

Series A$19.3MBoston, MA, US

Board Member· Board

Emerald Cloud Lab

Series C$92.1MSouth San Francisco, CA, US

Board Member· Board

Schooner Capital

Investment FirmBoston, MA, US

Managing Partner

2013 – 2023

ABS Ventures

Investment FirmWaltham, MA, US

General Partner

People Similar to Scott Yaphe

Teresa B DickeyBoard Member · Net Medical Xpress Solutions

Daniel BrodieCo-Founder · Cynerio

Abhishek AgarwalBoard Member · Cyberstarts

Asheem ChandnaBoard Member · Palo Alto Networks

Leadership at Selux Diagnostics

Aleksandar VacicCo-Founder

Eric SternCo-Founder

Steve LufkinCEO

Similar to Selux Diagnostics

Specific DiagnosticsMountain View, CA, USAntibiotic Susceptibilityest. 2011Specific DiagnosticsMountain View, CA, US · est. 2011

Global pioneer in rapid antibiotic susceptibility solutions, Specific Diagnostics.

Series A · $15.9M175

Accelerate DiagnosticsTucson, AZ, USDiagnostics, Medical Devicesest. 2004Accelerate DiagnosticsTucson, AZ, US · est. 2004

Diagnostics firm offering automated antibiotic susceptibility results from blood cultures via Accelerate Pheno™ System.

Public · $264.1M179

Acenxion BiosystemsKansas City, KS, USDiagnostics, Testingest. 2020Acenxion BiosystemsKansas City, KS, US · est. 2020

Acenxion Biosystems develops rapid, automated systems for bacterial detection and antibiotic susceptibility testing, enhancing patient care.

Seed · $4.3M11

Astek DiagnosticsBaltimore, MD, USDiagnostics, Medical Devicesest. 2020Astek DiagnosticsBaltimore, MD, US · est. 2020

Astek Diagnostics develops Eugris, a platform for rapid antibiotic guidance in bacterial sepsis.

Seed · $2.4M14

Recent news

Green MarketplaceHotel News Resource · 2009

Some of the interest in new Sports Q Scores isn't at the topSports Business Journal · 2009

Dry cleaning is getting greener, but some efforts are spottyThe Seattle Times · 2008

Leadership at Hanger Network

JD SchulmanFounder

Jared D SchulmanBoard Member

Bob DavoliBoard Member

Similar to Hanger Network

HangItNew York City, NY, USMarketing Campaignsest. 2014HangItNew York City, NY, US · est. 2014

HangIt LLC: Operating a web portal for streamlined marketing campaigns.

Similar to ABS Ventures

ABS Capital PartnersBaltimore, MD, USest. 1990ABS Capital PartnersBaltimore, MD, US · est. 1990

ABS Capital Partners LP: A venture capital firm specializing in late-stage growth investments across various sectors.

Investment Firm20

AbstractSan Francisco, CA, USest. 2016AbstractSan Francisco, CA, US · est. 2016

Abstract Ventures: A California-based venture capital firm investing in early-stage tech and healthcare sectors.

Investment Firm8

AbbVie Biotech VenturesChicago, IL, USest. 2009AbbVie Biotech VenturesChicago, IL, US · est. 2009

ABVI: A US-based venture capital firm specializing in investments in biotech and pharmaceutical sectors.

Investment Firm10k

Altos VenturesMenlo Park, CA, USest. 1996Altos VenturesMenlo Park, CA, US · est. 1996

Altos Ventures: A global venture capital firm providing financing services to IT industries.

Investment Firm72

Leadership at eXIthera Pharmaceuticals

William KosterBoard Member

Neil HaywardFounder

Fred MeyerBoard Member

Similar to eXIthera Pharmaceuticals

Anthos TherapeuticsCambridge, MA, USBiopharmaceuticalsest. 2018Anthos TherapeuticsCambridge, MA, US · est. 2018

Anthos Therapeutics: Advancing CVM disease care through innovative, validated biopharmaceutical therapies.

Series A · $250M33

Thrombolytic ScienceCambridge, MA, USBiopharmaceuticals, Therapeuticsest. 2004Thrombolytic ScienceCambridge, MA, US · est. 2004

TSI, a Cambridge-based biopharmaceutical firm, pioneers in thrombolytic research for clot treatment since 2006.

Series A · $7.5M3

Initial TherapeuticsNew York City, NY, USMedicinesest. 2020Initial TherapeuticsNew York City, NY, US · est. 2020

Initial Therapeutics: An ATP company developing small-molecule medicines to prevent pathogenic protein synthesis.

Series A · $78.8M11

IschemixMaynard, MA, USDrugs, Pharmaceuticalsest. 1999IschemixMaynard, MA, US · est. 1999

Ischemix, Inc.: A Massachusetts-based pharmaceutical company specializing in small molecule drugs for ischemia-reperfusion injuries.

Series A · $6.6M7

Leadership at Censinet

Eric YablonkaBoard Member

Meg AranowBoard Member

Vin FabianiBoard Member

Ed GaudetCo-Founder

Stan NowakBoard Member

Keith FiglioliBoard Member

Similar to Censinet

CyberSaintBoston, MA, USRisk Managementest. 2016CyberSaintBoston, MA, US · est. 2016

CyberSaint, Inc. provides a risk management platform enhancing cyber security and resilience.

Leadership at Emerald Cloud Lab

Brian FrezzaCo-Founder

DJ KleinbaumCo-Founder

Similar to Emerald Cloud Lab

TranscripticMenlo Park, CA, USLab Services, Researchest. 2012TranscripticMenlo Park, CA, US · est. 2012

Transcriptic developed a robotic cloud laboratory platform before combining into Strateos in 2019.

StrateosMenlo Park, CA, USLab Automation, Researchest. 2019StrateosMenlo Park, CA, US · est. 2019

Strateos: A data-driven life science company advancing research efficiency through automation and robotics.

Series B · $105.8M83

PotatoIssaquah, WA, USAI Infrastructureest. 2023PotatoIssaquah, WA, US · est. 2023

Issaquah-based software company, Potato, innovates AI infrastructure to streamline model pipelines.

BenchlingSan Francisco, CA, USRD Platform, Softwareest. 2012BenchlingSan Francisco, CA, US · est. 2012

Benchling develops cloud software for biotechnology R&D, connecting scientific data, experiments, workflows, and research teams.

Series F · $411.9M808

Leadership at Schooner Capital

Vin RyanBoard Member

Similar to Schooner Capital

Squadron CapitalGranby, CT, USest. 2008Squadron CapitalGranby, CT, US · est. 2008

Squadron Capital, LLC: A US-based investment firm specializing in acquiring and investing in companies.

Investment Firm11

Sherbrooke CapitalNewton, MA, USest. 1999Sherbrooke CapitalNewton, MA, US · est. 1999

Sherbrooke Capital, L.L.C.: A private equity firm investing in health, wellness, and green living sectors.

Investment Firm8

Spinnaker CapitalBoston, MA, USest. 1997Spinnaker CapitalBoston, MA, US · est. 1997

Spinnaker Capital LLC, a Boston-based financial firm, invests in diverse industries and provides strategic advice and flexible financing solutions.

Investment Firm9

Schechter Private CapitalBirmingham, MI, USest. 2016Schechter Private CapitalBirmingham, MI, US · est. 2016

Schechter Private Capital: A US-based wealth advisory firm offering portfolio management, financial planning, and investment services.

Investment Firm15

Harte HanksSan Antonio, TX, USAdvertising, Marketingest. 1923

Harte HanksSan Antonio, TX, US · est. 1923

Harte-Hanks, Inc: A global direct marketing service provider, specializing in targeted advertising.

Public · $54.9M4.3k

Convenience NetworkKnoxville, TN, USAdvertising, Digital Signageest. 2009Convenience NetworkKnoxville, TN, US · est. 2009

Convenience Network is a digital media company, leveraging high-definition screens and interactive marketing to engage consumers at high-traffic retail locations.

Seed · $902.6k4

B2BWorksChicago, IL, USAdvertisingest. 1999B2BWorksChicago, IL, US · est. 1999

B2BWorks: Comprehensive online B2B advertising network service.

Series C · $20M125

TausightBoston, MA, USCybersecurity Softwareest. 2018

TausightBoston, MA, US · est. 2018

Boston-based software company specializing in advanced cybersecurity solutions for the U.S. healthcare industry.

Series A · $26M31

Bitsight TechnologiesBoston, MA, USCybersecurity Ratingsest. 2011Bitsight TechnologiesBoston, MA, US · est. 2011

BitSight, a Boston-based software company, provides cybersecurity ratings for over 200,000 organizations.

Late Stage Private · $651.6M896

CynetNew York City, NY, USSecurity, Threat Intelligenceest. 2015CynetNew York City, NY, US · est. 2015

Cynet: An Israel-born, Boston-based cybersecurity firm, specializing in threat intelligence and endpoint security.

Series C · $78M234